Oncobit enabling personalized cancer care by developing precise and highly sensitive diagnostic and monitoring tests.
Oncobit has raised €4.1M across 2 funding rounds from 4 investors, most recently a round in Dec 2025. Based in Zurich, Switzerland; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2025-12-04 | Other | €2.0M | Existing investors,new investors | View deal → |
| 2021-04-30 | Seed | €2.1M | AVANTECA Partners,GF Group Holding | View deal → |
